Pharmabiz4m
NeurAxis receives US FDA 510(k) clearance for RED for testing and evaluation of patients with chronic constipation
NeurAxis receives US FDA 510(k) clearance for RED for testing and evaluation of patients with chronic constipation: Carmel, Indiana Thursday, December 12, 2024, 16:00 Hrs [IST] Ne ...
Pharmabiz25m
Waters highlights continued progress towards sustainability commitments to reduce environmental impact
Waters highlights continued progress towards sustainability commitments to reduce environmental impact: Our Bureau, Bengaluru Thursday, December 12, 2024, 15:40 Hrs [IST] Waters h ...
Pharmabiz30m
AHPI unites corporate healthcare leaders to launch consortium for a TB-Free Uttar Pradesh
In a groundbreaking initiative aimed at accelerating the fight against tuberculosis (TB), healthcare leaders from corporate and private hospitals across Uttar Pradesh came together in Ghaziabad. The ...
Pharmabiz2h
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...
Pharmabiz2h
Orbis India sees bright future begins with clear vision calls for early eye care in children
Orbis India sees bright future begins with clear vision calls for early eye care in children: Our Bureau, Bengaluru Thursday, December 12, 2024, 13:50 Hrs [IST] Orbis India, a non ...
Pharmabiz1h
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain: Bethesda, Maryland Thursday, December 12, 2024, 15:00 Hrs [IST] The antiviral drug tecovirimat di ...
Pharmabiz2h
Cellectar Biosciences updates on clinical development on its proprietary phospholipid ether drug conjugate platform targeting cancers
Cellectar Biosciences updates on clinical development on its proprietary phospholipid ether drug conjugate platform targeting cancers: Florham Park, New Jersey Thursday, December ...
Pharmabiz2h
Inventurus Knowledge Solutions raises Rs. 1,120.18 crore from 61 anchor investors
Inventurus Knowledge Solutions raises Rs. 1,120.18 crore from 61 anchor investors: Our Bureau, Mumbai Thursday, December 12, 2024, 13:30 Hrs [IST] Inventurus Knowledge Solutions L ...
Pharmabiz4h
Daiichi Sankyo begins patient dosing in QuANTUM-Wild phase 3 trial of Vanflyta in newly diagnosed FLT3-ITD negative AML
Daiichi Sankyo begins patient dosing in QuANTUM-Wild phase 3 trial of Vanflyta in newly diagnosed FLT3-ITD negative AML: Tokyo Thursday, December 12, 2024, 12:00 Hrs [IST] The fir ...
Pharmabiz3h
Over 1 in 5 adults worldwide has a genital herpes infection – WHO
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released. At least 1 person each ...
Pharmabiz6h
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...
Pharmabiz5h
New advances in carbon ion therapy for challenging large tumours: Study
New advances in carbon ion therapy for challenging large tumours: Study: Krems, Austria Thursday, December 12, 2024, 11:00 Hrs [IST] A pioneering study has introduced a novel appr ...